Scholar Rock Holding (SRRK) Free Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.79% |
| Dec 31, 2025 | -9.45% |
| Sep 30, 2025 | 10.56% |
| Jun 30, 2025 | 2.27% |
| Mar 31, 2025 | -59.37% |
| Dec 31, 2024 | 5.62% |
| Sep 30, 2024 | -6.62% |
| Jun 30, 2024 | 1.14% |
| Mar 31, 2024 | -33.33% |
| Dec 31, 2023 | -15.73% |
| Sep 30, 2023 | 0.98% |
| Jun 30, 2023 | 24.35% |
| Mar 31, 2023 | -44.29% |
| Dec 31, 2022 | -16.30% |
| Sep 30, 2022 | 27.15% |
| Jun 30, 2022 | 17.99% |
| Mar 31, 2022 | -30.25% |
| Dec 31, 2021 | 17.61% |
| Sep 30, 2021 | -32.89% |
| Jun 30, 2021 | -4.44% |
| Mar 31, 2021 | -33.23% |
| Dec 31, 2020 | 14.14% |
| Sep 30, 2020 | -25.50% |
| Jun 30, 2020 | -865.42% |
| Mar 31, 2020 | 114.97% |
| Dec 31, 2019 | -4.82% |
| Sep 30, 2019 | -4.89% |
| Jun 30, 2019 | 0.39% |
| Mar 31, 2019 | -129.44% |
| Dec 31, 2018 | 665.89% |
| Sep 30, 2018 | 18.58% |
| Jun 30, 2018 | -19.28% |
| Mar 31, 2018 | -55.61% |
| Dec 31, 2017 | -13.67% |